Point72 Asset Management L.P. acquired a new stake in shares of Trupanion, Inc. (NASDAQ:TRUP – Free Report) during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund acquired 30,775 shares of the financial services provider’s stock, valued at approximately $1,483,000. Point72 Asset Management L.P. owned approximately 0.07% of Trupanion at the end of the most recent reporting period.
Several other institutional investors have also modified their holdings of the business. SBI Securities Co. Ltd. bought a new stake in Trupanion in the 4th quarter valued at approximately $25,000. Jones Financial Companies Lllp lifted its stake in Trupanion by 71.7% in the 4th quarter. Jones Financial Companies Lllp now owns 570 shares of the financial services provider’s stock valued at $27,000 after acquiring an additional 238 shares in the last quarter. Quarry LP bought a new stake in Trupanion in the 4th quarter valued at approximately $39,000. Aster Capital Management DIFC Ltd lifted its stake in Trupanion by 988.5% in the 4th quarter. Aster Capital Management DIFC Ltd now owns 1,132 shares of the financial services provider’s stock valued at $55,000 after acquiring an additional 1,028 shares in the last quarter. Finally, Coppell Advisory Solutions LLC lifted its stake in Trupanion by 58.3% in the 4th quarter. Coppell Advisory Solutions LLC now owns 1,249 shares of the financial services provider’s stock valued at $61,000 after acquiring an additional 460 shares in the last quarter.
Trupanion Trading Down 2.6%
Shares of Trupanion stock opened at $44.12 on Thursday. Trupanion, Inc. has a 12-month low of $25.90 and a 12-month high of $57.90. The stock has a market cap of $1.89 billion, a P/E ratio of -191.83, a P/E/G ratio of 6.02 and a beta of 1.72. The company has a quick ratio of 1.66, a current ratio of 1.71 and a debt-to-equity ratio of 0.39. The business’s 50 day moving average is $38.62 and its 200-day moving average is $44.14.
Analysts Set New Price Targets
Several research firms have commented on TRUP. Piper Sandler cut their target price on Trupanion from $57.00 to $52.00 and set an “overweight” rating on the stock in a research note on Thursday, February 20th. Lake Street Capital dropped their price objective on Trupanion from $65.00 to $60.00 and set a “buy” rating on the stock in a research note on Friday, May 2nd. Finally, Stifel Nicolaus dropped their price objective on Trupanion from $44.00 to $41.00 and set a “hold” rating on the stock in a research note on Thursday, February 20th. Two investment analysts have rated the stock with a hold rating, four have assigned a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat.com, Trupanion presently has a consensus rating of “Moderate Buy” and an average price target of $51.80.
View Our Latest Report on TRUP
Insider Buying and Selling
In related news, SVP Emily Dreyer sold 14,025 shares of the business’s stock in a transaction that occurred on Friday, March 7th. The stock was sold at an average price of $32.41, for a total transaction of $454,550.25. Following the transaction, the senior vice president now directly owns 27,645 shares of the company’s stock, valued at approximately $895,974.45. The trade was a 33.66% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Margaret Tooth sold 4,000 shares of the business’s stock in a transaction that occurred on Thursday, March 20th. The stock was sold at an average price of $37.17, for a total value of $148,680.00. Following the transaction, the chief executive officer now directly owns 118,784 shares in the company, valued at $4,415,201.28. The trade was a 3.26% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders have sold 33,792 shares of company stock valued at $1,122,802. 5.42% of the stock is owned by insiders.
About Trupanion
Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.
Featured Articles
- Five stocks we like better than Trupanion
- Find and Profitably Trade Stocks at 52-Week Lows
- $30B AI Opportunity: Will It Power Meta’s Next Surge?
- Retail Stocks Investing, Explained
- Microsoft Could Rally as EU Antitrust Case Nears Resolution
- The 3 Best Fintech Stocks to Buy Now
- Intel Refocuses: NEX Sale and Foundry Pivot Signal New Era
Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.